Clinical Trial Units
At any one time the University of Oxford sponsors around 1,000 academic designed and led clinical research studies within the EU of which about 150 are interventional trials ranging from phase I to phase IV. The University sponsors approximately 350 further studies outside the EU, largely through its Centre for Tropical Medicine and Global Health.
Our Clinical Trial Units
We run five UKCRC fully-registered specialist clinical trials units, supporting national, multinational and multicentre trials, ranging from phase I to phase IV.
Clinical Trial Management
Careers in clinical trial management, details of training and development courses and guidance for anyone interested in pursuing a career in trial management.
Participate in a Clinical Trial
If you are interested in participating in a clinical trial, this page contains links to Clinical Trial Units across the University and NHS that maybe recruiting participants.
Latest Clinical Trial News
International trial finds rapid diagnostic testing alone does not reduce antibiotic prescribing for respiratory infections
17 March 2026
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative study led by the University of Oxford and University of Antwerp, report that point-of-care diagnostic testing, when used alone is unlikely to reduce antibiotic prescribing for respiratory tract infections in primary care. The findings indicate that testing must be embedded within broader antimicrobial stewardship strategies to be effective.
Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate
13 March 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.
New Oxford-led trial explores if the immune system can be trained to control HIV
4 February 2026
Can the immune system be trained to control HIV without continuous medication? A new Oxford-led clinical trial is exploring whether immune-based strategies could support longer-term viral control after stopping antiretroviral therapy.